TCRT — Alaunos Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Alaunos Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	76.1	39.1	6.06	1.09	1.39
Net Total Accounts Receivable
Net Total Receivables	1.11	0.004	0.001	0.005	0.003
Prepaid Expenses
Total Other Current Assets
Total Current Assets	78.8	53.8	8.26	2.75	1.99
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	15.4	10.6	0.002	0	0.091
Other Long Term Assets
Total Assets	94.9	64.9	8.26	2.75	2.97
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	16	24.2	1.96	0.692	0.813
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	36.8	26.4	1.96	0.692	0.813
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	58.1	38.6	6.31	2.06	2.15
Total Liabilities & Shareholders' Equity	94.9	64.9	8.26	2.75	2.97
Total Common Shares Outstanding
Total Preferred Shares Outstanding